Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of ABBV-553 assessing pharmacokinetics, safety and tolerability in healthy volunteers and psoriasis patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ABBV-553 (ABBV-553)

Snippet

Sponsor: AbbVie | Conditions: Psoriasis | Phase 1 | Status: TERMINATED